Research Alliance Corp III (RACC) stock
RACCNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 16, 2026
$10.12+0.00 (0.00%)
Close on Nov 17, 2026Market cap $92.08MP/E –Yield –
Research Alliance Corp III total assets
Total assets on the balance sheet at the end of each period.
Research Alliance Corp III's total assets was $78.90M at Sep 30, 2026.
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $78.90M | – |
| Q2 FY2026 | Jun 30, 2026 | $76.31M | – |
| Q1 FY2026 | Mar 31, 2026 | $732.92K | – |
See a number that looks wrong?